Bepotastine Besilate Market In Global
Bepotastine is a non-sedating, selective antagonist of histamine 1 (H1) receptor with pIC50 of 5. ... Read More
Mizolastine is a second generation antihistamine agent with high affinity and specificity for histamine H1 receptors.
This report contains market size and forecasts of Mizolastine in global, including the following market information:
Global Mizolastine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Mizolastine Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Mizolastine companies in 2021 (%)
The global Mizolastine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mizolastine include Merck, TCI, Santa Cruz Biotechnology, Adooq Bioscience, AbMole, United States Biological, Sinopaharrm Chemical Reagent, Key Organics and Biorbyt, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mizolastine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mizolastine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Mizolastine Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Mizolastine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Mizolastine Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Mizolastine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Mizolastine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mizolastine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Mizolastine revenues share in global market, 2021 (%)
Key companies Mizolastine sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Mizolastine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
TCI
Santa Cruz Biotechnology
Adooq Bioscience
AbMole
United States Biological
Sinopaharrm Chemical Reagent
Key Organics
Biorbyt
Biosynth Carbosynth
Spectrum Chemical
LGC
BOC Sciences
Bepotastine is a non-sedating, selective antagonist of histamine 1 (H1) receptor with pIC50 of 5. ... Read More
Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6 ... Read More
Indoximod, a methylated tryptophan, acts as an IDO (indoleamine-(2,3)-dioxygenase) pathway inhibi ... Read More
Epacadostat is a potent and selective indoleamine 2,3-dioxygenase (IDO1) inhibitor.
... Read More